The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Some tumors contain cells that are both SCLC and a form of NSCLC (often large cell), according to the GO 2 for Lung Cancer foundation. (1) Doctors must know the type of cancer you have to ...

It started with a dull ache in my right shoulder. At first, I chalked it up to bad posture or sleeping funny. Then came a ...

Former President Joe Biden has been diagnosed with an “aggressive” form of prostate cancer that has spread to his bones. But ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But ...

Biden was treated for a blood clot in his lung in 1988, per The Washington Post. The clot came one month after the ...

As vice president under President Barack Obama, Biden led the Cancer Moonshot to spur research into new treatments. As ...